Drug intelligence / Profile preview

hypericin

Development stage
Phase 3
Lead developer
Soligenix
Modality
Light/Condition-Responsive Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules
Administration
Oral, Topical, Intravenous
01

Overview

Hypericin is a naturally occurring carbopolycyclic compound and phenanthroperylene quinone found in various species of the genus *Hypericum*, most notably *Hypericum perforatum* (St. John’s wort)[1][4]. It is structurally complex and photosensitive. Traditionally used in folk medicine as part of St. John’s wort extracts for its antidepressant properties[1][4], hypericin has more recently been investigated as a multifunctional agent with antineoplastic (anticancer), antiviral (notably against HIV and hepatitis C), photodynamic therapeutic (PDT), and diagnostic applications[2][3][4][5]. Its mechanism of action includes photodynamic activation leading to free radical production for cancer therapy; it also exhibits inhibitory effects on several enzymes such as monoamine oxidase (MAO), protein kinase C (PKC), dopamine-beta-hydroxylase, reverse transcriptase, telomerase and cytochrome P450[4]. Synthetic forms are under clinical investigation for cutaneous T-cell lymphoma using topical administration with light activation[7][10].

Brand names
HyBryte
Other names
hypericinHIPERICINHipericinaHypéricineHypericum redHyperizin
02

Targets

TERT (Telomerase)Human immunodeficiency virus type 1 reverse transcriptaseMAOA (Monoamine oxidase A)PKC (Protein kinase C family)Cyp (Cyclophilin family)

Beyond the preview

Go deeper on hypericin.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on hypericin.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call